Breaking News, Collaborations & Alliances

Pilgrim, QPharma Form Operational Alliance

Pilgrim Software, Inc. and QPharma, Inc. have agreed to make QPharma’s set of validation, quality and regulatory compliance consulting services available to customers in collaboration with Pilgrim’s SmartSolve suite of products.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pilgrim Software, Inc. and QPharma, Inc. have agreed to make QPharma’s set of validation, quality and regulatory compliance consulting services available to customers in collaboration with Pilgrim’s SmartSolve suite of products.

Pilgrim offers integrated risk, compliance and quality management solutions designed to help highly regulated organizations remain compliant, recognize and address potential operational dangers, reduce costs, and operate more effectively. Through the Pilgrim alliance, QPharma will leverage its Professional Services Business Unit for regulatory compliance spanning the product development lifecycle, from quality and validation solutions, to PDMA and fulfillment services.

“We are delighted to be working with Pilgrim Software,” said Ray Roggero, chief operating officer of QPharma. “It’s a natural fit with Pilgrim’s integrated risk, compliance and quality management solution, and by leveraging the natural synergies between Pilgrim and QPharma, organizations can gain an effective, practical roadmap for reaching their quality and regulatory compliance goals.”

QPharma’s offerings address a broad range of quality services from auditing, to documentation development, to enterprise-wide validation and compliance remediation programs. “Pilgrim and QPharma share a vision of executing successful software implementations, with knowledgeable consulting and support, that help organizations improve operational performance and ensure compliance with industry and regulatory standards,” said Prashanth Rajendran, chief operating officer for Pilgrim Software.


Click here to learn more about Pilgrim Software

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters